Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Point of Care Diagnostics - Economic Reimbursement & Technology Trends

24 Oct 2012 - 25 Oct 2012 - London, UK



Bookmark and Share


SMi present their 9th annual Point of Care Diagnostics conference, which will bring together key members of the diagnostics and healthcare industries to discuss the implementation of technology, the reimbursements of the industry, and the connectivity of point of care technology throughout Europe and the world.

Benefits of Attending:

· Network with diagnostic manufacturers, pharmaceutical specialists and key healthcare practitioners working with POC technology

· Explore the economics, market developments, connectivity and the controversial topics of the POC industry

· Learn about the current market pulls and emerging technologies, and the ways they affect the medical diagnostics industry

· Discuss the POC industry, its potential expansion into wider markets and its future in the NHS and in European healthcare

· Consider new emerging technologies, and speak to the industry leaders at the forefront of development, manufacture and usage

Keynote Speakers include:

· Thomas Li, Senior Director, Technology Management, Roche Diagnostics, Singapore 

· Hans Winkler, Senior Director, Biomarkers, Janssen R&D (a Johnson & Johnson company) 

· David Huckle, President & Director General, ABA – France 

· Gilbert Greub, Chief of Medicine, Institute of Microbiology 

· Christopher Lowe, Director of the Institute of Biotechnology, University of Cambridge 

PLUS 2 INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS 

Tuesday 23rd of October, 2012, Copthorne Tara Hotel, London

A: Health economics, reimbursement, and market access for POC technologies

Workshop Leader: Kuo Tong, President & Founder, Quorum Consulting

8:30 – 12:30

B: The Future of Healthcare: Connecting the vision

Workshop leader: Simon Burnell, Partner, PA Consulting

13:30 – 17:30 pm

***Book before 31st May 2012 and save £300***

***Book before 29th June 2012 and save £100***

Visit our website here: http://www.smi-online.co.uk/goto/2012pointofcare8.asp

Alternatively Contact Shilan Chandi on tel: +44 (0) 20 7827 6738 or email: schandi@smi-online.co.uk



Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!